ELP1 and melanoma: Since dynamic IKAP/Elp1 phosphorylation was also observed in human melanoma cells [32] and change in response to insulin availability, pharmacological interference with this process may represent an attractive option to downregulate the Elongator function and possibly impair cancer cell proliferation.